Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and ...

Lilly's drug is one of several being tested to treat high Lp(a), a risk factor for heart disease that affects an estimated ...

In a statement, Eli Lilly said it is "investigating orforglipron for the potential to bring a safe and effective treatment to ...

LillyDirect will help provide services to millions of patients who have yet to be formally diagnosed with the disease.

Eli Lilly's Alzheimer's treatment is approved for use in the U.S. but the European Medicines Agency recommended against the ...

Eli Lilly has linked lepodisiran to sustained reductions in a cardiovascular disease risk factor for nearly 1.5 years, bolstering the company’s argument that the siRNA candidate has an edge over ...

Hollywood has in recent years been undergoing a much-needed, long-awaited transformation in its portrayals of women and ...

A European regulatory committee rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over potentially dangerous ...

In honor of Equal Pay Day, March 25, PEOPLE is exclusively debuting the first trailer for Lilly, in which Patricia Clarkson ...